Thorne HealthTech

Thorne HealthTech, Inc. is engaged in the provision of a total system for wellness. It utilizes testing and data to create improved product quality and deliver personalized solutions to consumers, health professionals, and professional sports teams. It also helps pharmaceutical and biotechnology companies repurpose existing drugs and compounds, improve existing medications and develop new products. The company was founded by Paul Jacobson in 2010 and is headquartered in New York, NY.

Earnings data Q2 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW YORK , Oct. 16, 2023 /PRNewswire/ -- L Catterton, a leading global consumer-focused investment firm, today announced the successful completion of its acquisition of Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness. "As consumer investors, we closely follow enduring secular trends, including the consumer's increasing prioritization of health and wellness," said Marc Magliacano, co-Managing Partner of the Flagship Fund at L Catterton.

L Catterton Completes Acquisition of Thorne HealthTech, Inc.

NEW YORK , Oct. 13, 2023 /PRNewswire/ -- L Catterton and Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN) today announced that the tender offer to purchase all of the issued and outstanding shares of Thorne's common stock ("Shares") for $10.20 per Share, net to the seller in cash, without interest and less any required withholding taxes (the "Offer"), expired as scheduled at one minute past 11:59 p.m., Eastern Time, on October 12, 2023 and was not extended (such date and time, the "Expiration Time").

L Catterton and Thorne HealthTech, Inc. Announce Expiration of Tender Offer

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Thorne HealthTech, Inc. (NasdaqGS: THRN) to L Catterton. Under the terms of the proposed transaction, shareholders of Thorne will receive $10.20 in cash for each share of Thorne that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the con.

THORNE HEALTHTECH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Thorne HealthTech, Inc. -THRN

MILWAUKEE , Aug. 28, 2023 /PRNewswire/ -- Ademi LLP is investigating Thorne (Nasdaq: THRN) for possible breaches of fiduciary duty and other violations of law in its transaction with L Catterton. Click here to learn how to join the action https://www.ademilaw.com/case/ thorne-healthtech-inc or call Guri Ademi toll-free at 866-264-3995.

Shareholder Alert: Ademi LLP investigates whether Thorne HealthTech, Inc. has obtained a Fair Price in its transaction with L Catterton

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Thorne HealthTech, Inc. (NASDAQ: THRN) to L Catterton for $10.20 per share in cash is fair to Thorne shareholders. Halper Sadeh encourages Thorne shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Thorne and its b.

THRN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Thorne HealthTech, Inc. Is Fair to Shareholders

Thorne HealthTech Inc. stock THRN, +5.97% was up 29% in premarket trades on Monday after it said it agreed to be taken private by L Catterton for $10.20 a share in cash in a deal valued at $680 million. The price amounts to a premium of 94% over Thorne HealthTech's unaffected closing share price on July 20.

Thorne HealthTech stock posts big gain on go-private merger with L Catterton

L Catterton to Commence a Tender Offer for all of Thorne's Outstanding Shares of Common Stock Thorne Stockholders to Receive $10.20 per Share in Cash, Representing a 94% Premium to the Unaffected Price Independent Special Committee and Thorne Board of Directors Unanimously Approve Transaction and Recommend that All Stockholders Tender Their Shares in the Tender Offer  NEW YORK, Aug. 28, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne" or the "Company") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it has entered into a definitive agreement under which L Catterton, a leading global consumer-focused investment firm, will commence a tender offer to acquire all outstanding shares of common stock of Thorne for $10.20 per share in cash. The transaction value of approximately $680 million represents a 94% premium to the unaffected closing share price on July 20, 2023, and a 113% premium to the 30-day volume weighted average price as of the unaffected date of July 20, 2023.

Thorne HealthTech, Inc. Enters into Definitive Agreement to be Acquired by L Catterton for $10.20 Per Share in Cash

HealthEquity

Investors interested in Medical Services stocks are likely familiar with Thorne Healthtech, Inc. (THRN) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?

THRN vs. HQY: Which Stock Should Value Investors Buy Now?

Thorne HealthTech, Inc (NASDAQ:THRN ) Q2 2023 Earnings Conference Call August 8, 2023 5:00 PM ET Company Participants Thomas Wilson - Vice President, Investor Relations Paul Jacobson - Chief Executive Officer Saloni Varma - Chief Financial Officer Tom McKenna - Chief Operating Officer Conference Call Participants Susan Anderson - Canaccord Genuity Patrick McNally - Evercore Operator Thank you for standing by. My name is Dina, and I will be your conference operator for today.

Thorne HealthTech, Inc (THRN) Q2 2023 Earnings Call Transcript

Record Net Sales With Growth of 33.1%; Raises Full-Year Guidance Midpoints for Net Sales and Gross Margin NEW YORK , Aug. 8, 2023  /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ: THRN), a leader in delivering personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the second quarter ended June 30, 2023. Second Quarter Highlights: Net sales grew 33.1% year-over-year to $72.7 million, with direct-to-consumer ("DTC") sales growth of 39.3% Gross profit grew 35.7% year-over-year to $40.6 million; gross profit as a % of net sales increased year-over-year to 55.9%.

Thorne HealthTech Reports Second Quarter 2023 Results

Company Withdraws Participation in the Canaccord Genuity 43rd Annual Growth Conference on Aug. 10 NEW YORK , Aug. 1, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, will release its second quarter 2023 financial results after market close on Tuesday, Aug. 8, 2023. The company will host a conference call to discuss its results on Tuesday, Aug. 8, 2023, at 5:00 p.m.

Thorne HealthTech Schedules Second Quarter 2023 Earnings Release and Conference Call for August 8

NEW YORK , July 28, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (the "Company") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it will participate in the Canaccord Genuity 43rd Annual Growth Conference in Boston. On Thursday, Aug. 10, at 10:30 a.m.

Thorne HealthTech to Participate in the Canaccord Genuity 43rd Annual Growth Conference on August 10

Atossa Genetics

Skeena Resources Ltd

The conventional definition of a penny stock is one that trades below $1. However, it's more common to define a penny stock as any stock that trades for less than $5.

3 Penny Stocks Set to Pass the $5 Mark Soon

NEW YORK , June 15, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that its NanoDrop device has received a CE (Conformite Europeenne) Mark certification and has successfully fulfilled the European Union's relevant performance, safety, and product requirements. NanoDrop expands Thorne's line of innovative health-care solutions, bringing virtually painless blood collection to decentralized clinical trials and at-home diagnostic testing.

Thorne HealthTech's At-Home Blood Sampling Device - NanoDrop - Earns CE Mark Certification in the European Union

NEW YORK , May 30, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (the "Company") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it will participate in TD Cowen's 7th Annual Future of the Consumer Conference in New York City. On Wednesday, June 7, at 10:45 a.m.

Thorne HealthTech to Participate in TD Cowen's 7th Annual Future of the Consumer Conference on June 7

NEW YORK , May 15, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it is entering into a research and development partnership agreement with Arome Science, a leader in metabolomics, to develop a next-generation metabolomics test. Arome Science and Thorne will collaborate to develop a commercial metabolomics wellness test.

Thorne HealthTech Enters into Research and Development Partnership with Arome Science to Develop Next-Generation Metabolomics Test

Thorne HealthTech, Inc. (NASDAQ:THRN ) Q1 2023 Earnings Conference Call May 11, 2023 5:30 PM ET Company Participants Thomas Wilson - VP, IR Paul Jacobson - CEO Saloni Varma - CFO Tom McKenna - COO Michelle Crow - CMO Conference Call Participants Sean Dodge - RBC Elizabeth Anderson - Evercore Susan Anderson - Canaccord Steven Mah - TD Cowen Operator Good afternoon. Thank you for attending today's Thorne HealthTech, Inc. First Quarter 2020 Earnings Call.

Thorne HealthTech, Inc. (THRN) Q1 2023 Earnings Call Transcript

Net Sales Growth of 20.7%; Reaffirms Full-Year 2023 Guidance NEW YORK , May 11, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ: THRN), a leader in delivering personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the first quarter ended March 31, 2023. First Quarter Highlights: Net sales grew 20.7% year-over-year to $65.2 million, with direct-to-consumer ("DTC") sales growth of 41.0% Gross profit grew 16.3% year-over-year to $34.3 million; gross profit as a % of net sales decreased year-over-year to 52.5% Net loss attributable to Thorne HealthTech, Inc. of $(0.4) million; adjusted EBITDA1 of $6.1 million Diluted earnings per share ("EPS") of $(0.01); adjusted diluted EPS1 of $0.06 Named to Fast Company's annual list of the most innovative companies in wellness for 2023 "We delivered strong sales performance across the business during the first quarter," said Paul Jacobson, Thorne HealthTech's chairman and CEO.

Thorne HealthTech Reports First Quarter 2023 Results

NEW YORK , May 3, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (the "Company") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it will participate in the 2023 RBC Capital Markets Global Healthcare Conference in New York City. On Tuesday, May 16 at 3:35 p.m.

Thorne HealthTech to Participate in the 2023 RBC Capital Markets Global Healthcare Conference on May 16

NEW YORK , May 3, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that its OneDraw® Blood Collection Device has been selected as the Best Overall Medical Device Product in the eighth annual MedTech Breakthrough Awards program. MedTech Breakthrough is an independent market intelligence organization that recognizes the "breakthrough" companies, individuals, platforms, and products in today's health, fitness, and medical technology industries.

Thorne HealthTech Wins 2023 MedTech Breakthrough Award for Best Overall Medical Device Product for Thorne's OneDraw® Blood Collection Device

NEW YORK , May 1, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, will release its first quarter 2023 financial results after market close on Thurs, May 11, 2023. The company will host a conference call to discuss its results on Thurs, May 11, 2023, at 5:30 p.m.

Thorne HealthTech Schedules First Quarter 2023 Earnings Release and Conference Call

Thorne HealthTech, Inc. (NASDAQ:THRN ) Q4 2022 Earnings Conference Call March 31, 2023 8:00 AM ET Company Participants Thomas Wilson – Vice President-Investor Relations Paul Jacobson – Chief Executive Officer Michelle Crow – Chief Medical Officer Tom McKenna – Chief Operating Officer Conference Call Participants Elizabeth Anderson – Evercore Susan Anderson – Canaccord Genuity Steven Mah – Cowen Operator Hello everyone, and welcome to the Thorne HealthTech Fourth Quarter 2022 Earnings Call. My name is Charlie and I'll be coordinating the call today.

Thorne HealthTech, Inc. (THRN) Q4 2022 Earnings Call Transcript

Net Sales Growth of 24.1% and Adj. EBITDA1 growth of 19.1% for Full-Year 2022; Provides Full-Year 2023 Guidance NEW YORK , March 30, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, today announced its financial results for the fourth quarter and full-year ended December 31, 2022.

Thorne HealthTech Reports Fourth Quarter and Full-Year 2022 Results

NEW YORK , March 29, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, will release its fourth quarter and full-year 2022 financial results after market close on Thurs, Mar. 30, 2023. The company will host a conference call to discuss its results on Fri, Mar. 31, 2023, at 8 a.m.

Thorne HealthTech Announces Fourth Quarter and Full-Year 2022 Earnings Release Date and Conference Call

NEW YORK , March 13, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne" or "Thorne HealthTech") (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellness, today announced that it has appointed Saloni Varma as Chief Financial Officer (CFO). As CFO, Varma will lead all aspects of the company's Accounting and Finance functions including budgeting planning and analysis, accounting, SEC reporting, tax, treasury, and investor relations.

News for Thorne HealthTech Stock (THRN)